Clinical Trial

3DUS Imaging of Needles in Gynecological Brachytherapy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Brachytherapy treatment in gynecological cancers is an essential component to delivering adequate doses of radiation to a tumour while sparing normal tissue. Interstitial or intra-cavitary brachytherapy are often needed in advanced or recurrent disease, in cases where intrauterine brachytherapy may not deliver the optimal outcome. Interstitial or intra-cavitary brachytherapy are based on a defined template-and-needle system, and the procedure relies on clinical examination and pre-treatment imaging to guide needle insertion. There is currently no standard image-guided process to help direct needles in the pelvis. We propose using 3D ultrasound to provide real-time imaging for the brachytherapy procedure, which will aid in avoiding needle insertion into pelvic organs and result in optimal dose coverage to the tumour.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-01-11; most recent amendment 2025-04-09.
Status change: Not Yet Recruiting → Recruiting 2023-05-15
Trial Details
NCT Number NCT04705467
Lead Sponsor Western University, Canada
Conditions Gynecologic Cancer
Enrollment 35 participants
Start Date 2022-10-15
Primary Completion 2025-10 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-04-13